Cyclo Therapeutics Announces Inclusion in the Russell 2000® Index
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from diseases, today announced that as part of the annual reconstitution of the Russell stock indexes, Cyclo Therapeutics has been selected to be added to the Russell 2000 Index effective June 25, 2021, after the close of the U.S. equity markets.
- Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from diseases, today announced that as part of the annual reconstitution of the Russell stock indexes, Cyclo Therapeutics has been selected to be added to the Russell 2000 Index effective June 25, 2021, after the close of the U.S. equity markets.
- The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity market.
- The Russell 2000 Index is a subset of the Russell 3000 Index representing approximately 10% of the total market capitalization of that index.
- It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership.